Cloning, expression, and pharmacological characterization of a novel human histamine receptor.
暂无分享,去创建一个
C. M. Davenport | H. Sarau | R. Ames | Yuan-E Zhu | L. Vawter | D. Bergsma | Shelagh Wilson | L. Fitzgerald | S. Wilson | J. Hieble | L. Tierney | H. Wu | R. Boyce | J. Alston | R. Boyce | H Wu | H M Sarau | D Michalovich | D. Michalovich | S Wilson | D J Bergsma | Y. Zhu | Xiaotong Li | C M Davenport | Y Zhu | K B Tan | G M Dytko | I J Mannan | R Boyce | J Alston | L A Tierney | X Li | N C Herrity | L Vawter | R S Ames | J P Hieble | L R Fitzgerald | J. Alston | N. Herrity | K. Tan | G. Dytko | I. J. Mannan | X. Li | J. Hieble | Hsiao-ling Wu | Colleen Davenport | I. Mannan
[1] J. Schwartz,et al. Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.
[2] M. Jackson,et al. Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.
[3] M. Uhler,et al. Molecular cloning of a gene encoding the histamine H2 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[4] Fabienne,et al. Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-a, $3, and -y in the Adult Rat* , 2001 .
[5] Y. Horio,et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Nalwalk,et al. Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats , 1997, Brain Research.
[7] R. Egan,et al. Identification of two H3-histamine receptor subtypes. , 1990, Molecular pharmacology.
[8] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. , 1993, Nature.
[9] P. Nambi,et al. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors. , 1994, The Journal of pharmacology and experimental therapeutics.
[10] D. J. Beer,et al. The influence of histamine on immune and inflammatory responses. , 1984, Advances in immunology.
[11] L. Fitzgerald,et al. Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay. , 1999, Analytical biochemistry.
[12] P. Cumming,et al. Characterization of the antinociceptive properties of cimetidine and a structural analog. , 1996, The Journal of pharmacology and experimental therapeutics.
[13] M. Billah,et al. The profiles of human and primate []N∝-methylhistamine binding differ from that of rodents , 1999 .
[14] W. Wahli,et al. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. , 1996, Endocrinology.
[15] Jian-guo Li,et al. Nucleoside diphosphate kinase associated with membranes modulates μ-opioid receptor-mediated []GTPγS binding and agonist binding to μ-opioid receptor , 1999 .
[16] E. Bissonnette,et al. Importance of Histamine in the Cytokine Network in the Lung Through H2 and H3 Receptors: Stimulation of IL-10 Production1 , 2000, The Journal of Immunology.
[17] O. Zuiderveld,et al. Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus , 1998, Brain Research.
[18] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα , 1993, Nature.
[19] N. Chaudhari,et al. An Optimized Method for In Situ Hybridization with Signal Amplification That Allows the Detection of Rare mRNAs , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[20] T. Watanabe,et al. Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues. , 1994, Japanese journal of pharmacology.
[21] A. Falus,et al. Histamine: an early messenger in inflammatory and immune reactions. , 1992, Immunology today.
[22] K. Melmon,et al. A histamine derivative increases intracellular calcium mobilization and oxidative metabolism in HL-60 cells. , 1993, Immunopharmacology.
[23] R. Leurs,et al. Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?. , 1996, The Journal of pharmacology and experimental therapeutics.
[24] J. Chambers,et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. , 1999, Molecular pharmacology.
[25] H. Sarau,et al. Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid. , 2000, Biochemical and biophysical research communications.
[26] K. Melmon,et al. The effects of derivatives of histamine on natural suppressor cells. , 1986, Journal of immunology.
[27] D. Bergsma,et al. Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. , 1997, Trends in pharmacological sciences.
[28] E. Schulman,et al. Pharmacologic characterization of a novel histamine receptor on human eosinophils. , 1994, American journal of respiratory and critical care medicine.
[29] J. Black,et al. Evidence that histamine homologues discriminate between H3‐receptors in guinea‐pig cerebral cortex and ileum longitudinal muscle myenteric plexus , 1999, British journal of pharmacology.
[30] Y. Masuho,et al. Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.